Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2004 Oct 18;2004(4):CD004391.
doi: 10.1002/14651858.CD004391.pub2.

Intramuscular arteether for treating severe malaria

B B Afolabi  1 , C N Okoromah
Affiliations
Meta-Analysis

Intramuscular arteether for treating severe malaria

B B Afolabi et al. Cochrane Database Syst Rev. .

Abstract

Background: Quinine and artemisinin drugs are used in severe malaria, but quinine resistance is increasing. Arteether is a recently developed artemisinin derivative that is oil soluble, has a long elimination half life, and is more stable than other derivatives.

Objectives: To compare intramuscular arteether with other antimalarial drugs to treat severe malaria.

Search strategy: We searched the Cochrane Infectious Diseases Group Specialized Register (August 2004), CENTRAL (The Cochrane Library Issue 3, 2004), MEDLINE (1966 to August 2004), EMBASE (1980 to August 2004), U.S. National Library of Medicine (NLM) Gateway (1953 to 1965), Web Science Citation (1981 to August 2004), LILACS (August 2004), Google search engine (August 2004), conference proceedings, and reference lists. We also contacted researchers, organizations, and pharmaceutical companies to help identify trials.

Selection criteria: Randomized and quasi-randomized controlled trials of intramuscular arteether in adults and children with severe malaria.

Data collection and analysis: We independently assessed the methodological quality of the trials and extracted data, and analysed data using Review Manager 4.2.

Main results: Two small trials (n = 194) met the inclusion criteria. Both trials compared arteether with quinine in children with cerebral malaria and reported on similar outcomes. There was no statistically significant difference in the number of deaths (relative risk 0.75, 95% confidence interval 0.43 to 1.30; n = 194, 2 trials), neurological complications (relative risk 1.18, 95% confidence interval 0.31 to 4.46; n = 58, 1 trial), or other outcomes including time to regain consciousness, parasite clearance time, and fever clearance time. The meta-analyses lack statistical power to detect important differences.

Reviewers' conclusions: More trials with a larger number of participants are needed before a firm conclusion about the efficacy and safety of arteether can be reached.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1.1
1.1. Analysis
Comparison 1 Arteether versus quinine, Outcome 1 Death.
1.2
1.2. Analysis
Comparison 1 Arteether versus quinine, Outcome 2 Neurological complications at follow up.
1.3
1.3. Analysis
Comparison 1 Arteether versus quinine, Outcome 3 Time to regain consciousness (hours).
1.4
1.4. Analysis
Comparison 1 Arteether versus quinine, Outcome 4 Parasite clearance time (hours).
1.5
1.5. Analysis
Comparison 1 Arteether versus quinine, Outcome 5 Presence of parasites at day 7.
1.6
1.6. Analysis
Comparison 1 Arteether versus quinine, Outcome 6 Presence of parasites at day 28.
1.7
1.7. Analysis
Comparison 1 Arteether versus quinine, Outcome 7 Fever clearance time (hours).
1.8
1.8. Analysis
Comparison 1 Arteether versus quinine, Outcome 8 People with any adverse events.
1.9
1.9. Analysis
Comparison 1 Arteether versus quinine, Outcome 9 People with serious adverse events.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD004391

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Moyou 2001 {published and unpublished data}
    1. Moyou‐Somo R, Tietche F, Ondoa M, Kouemeni LE, Ekoe T, Mbonda E, et al. Clinical trial of beta‐arteether versus quinine for the treatment of cerebral malaria in children in Yaounde, Cameroon. American Journal of Tropical Medicine and Hygiene 2001;64(5‐6):229‐32. - PubMed
Thuma 2000 {published data only}
    1. Thuma PE, Bhat GJ, Mabeza GF, Osborne C, Biemba G, Shakankale GM, et al. A randomized controlled trial of artemotil (beta‐arteether) in Zambian children with cerebral malaria. American Journal of Tropical Medicine and Hygiene 2000;62(4):524‐9. - PubMed

References to studies excluded from this review

Asimus 2007 {published data only}
    1. Asimus S, Elsherbiny D, Hai TN, Jansson B, Huong NV, Petzold MG, et al. Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects. Fundamental & Clinical Pharmacology 2007;21(3):307‐16. - PubMed
Asthana 2001 {published data only}
    1. Asthana OP, Srivastava JS, Pandey TK, Vishwanathan KA, Dev V, Mahapatra KM, et al. Multicentric clinical trials for safety an efficacy evaluation of alpha;beta arteether in complicated P. falciparum malaria. Journal of the Association of Physicians of India 2001;49:1155‐60. - PubMed
Mishra 1995 {published data only}
    1. Mishra SK, Asthana OP, Mohanty S, Patnaik JK, Das BS, Srivastava JS, et al. Effectiveness of alpha,beta‐arteether in acute falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89(3):299‐301. - PubMed
Mohanty 1997 {published data only}
    1. Mohanty S, Mishra SK, Satpathy SK, Dash S, Patnaik J. alpha, beta‐Arteether for the treatment of complicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91(3):328‐30. - PubMed
Pareek 2006 {published data only}
    1. Pareek A, Nandy A, Kochar D, Patel KH, Mishra SK, Mathur PC. Efficacy and safety of beta‐arteether and alpha/beta‐arteether for treatment of acute Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene 2006;75(1):139‐42. - PubMed
Shukla 2002 {published data only}
    1. Shukla UK, Damle RK, Shukla MM, Singh N. Efficacy of alpha, beta ‐ Arteether in children with cerebral malaria in forested tribal belt. Indian Pediatrics 2002;39(6):565‐8. - PubMed
Singh 2007 {published data only}
    1. Singh RK. Efficacy of combined treatment with alpha/beta‐arteether and sulfadoxine‐pyrimethamine, for cases of Plasmodium falciparum malaria in Jharkhand, India. Annals of Tropical Medicine and Parasitology 2007;101(3):271‐3. - PubMed

Additional references

Brewer 1994
    1. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, et al. Fatal neurotoxicity of arteether and artemether. American Journal of Tropical Medicine and Hygiene 1994;51(3):251‐9. - PubMed
de Vries 1996
    1. Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996;52(6):818‐36. - PubMed
Jüni 2001
    1. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42‐6. - PMC - PubMed
Kain 1995
    1. Kain KC. Chemotherapy and prevention of drug‐resistant malaria. Wilderness and Environmental Medicine 1995;6(3):307‐24. - PubMed
Lefebvre 2008
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Lugt 2002
    1. Lugt CB. Dutch registration for artemotil injections. www.who.int/tdr/publications/tdrnews/news63/artemotil.htm (accessed June 2002).
McIntosh 2003
    1. McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD000527] - DOI - PMC - PubMed
Mutanda 1999
    1. Mutanda LN. Assessment of drug resistance to the malaria parasite in residents of Kampala, Uganda. East African Medical Journal 1999;76(8):421‐4. - PubMed
Okitolonda 1987
    1. Okitolonda W, Delacollete C, Malengreau M, Henquin JC. High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. BMJ 1987;295(6600):716‐8. - PMC - PubMed
Review Manager 5 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Schulz 1996
    1. Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ 1996;312(7033):742‐4. - PMC - PubMed
White 1998
    1. White NJ, Olliaro P. Artemisinin and derivatives in the treatment of uncomplicated malaria. Medecine Tropicale 1998;58 Suppl 3:54‐6. - PubMed
White 2000
    1. White NJ. Malaria. In: Cook G editor(s). Manson's tropical diseases. 20th Edition. London: W.B. Saunders, 1996:1087‐164.
WHO 1990
    1. World Health Organization. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Transactions of the Royal Society of Tropical Medicine and Hygiene 1990;84 Suppl 2:1‐65. - PubMed
WHO 1993
    1. World Health Organization. The role of artemisinin and its derivatives in the current treatment of malaria (1994‐1995: report of an informal consultation, Geneva, 27‐29 September 1993). Geneva: World Health Organization, 1993.
WHO 2000
    1. World Health Organization. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000;94 Suppl 1:1‐90. - PubMed
WHO 2001
    1. World Health Organization. The use of antimalarial drugs. Report of an informal consultation. World Health Organization, Geneva 2001.
WHO 2002
    1. World Health Organization. Review of application for inclusion of a drug in the WHO Essential Drugs List: Artemotil and alpha/beta arteether (CDS/RBM, 18 March 2002). www.who.int/medicines/organization/par/edl/arteether_review.doc (accessed 29 April 2003).

LinkOut - more resources